Identification of Novel, Potent, and Selective Compounds against Malaria Using Glideosomal-Associated Protein 50 as a Drug Target.

ACS Omega · 2023 · PMC10586260 · PMID 37867646

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The finding of potent antiplasmodial activity in Bedaquiline and Brilacidin is highly significant since Bedaquiline is already being used against MDR-TB, 71 and Brilacidin is currently used in clinical trials as SARS-CoV2 drug.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.